Campaign news | Policy news | 16th May 2012

The Prostate Cancer Charity has welcomed today's announcement by the National Institute for Health and Clinical Excellence (NICE) that they are to recommend abiraterone - the breakthrough treatment for advanced prostate cancer - on the NHS in England and Wales, but has vowed to continue campaigning until the drug is available on the NHS for all men who need it throughout the UK.

Policy news | 11th May 2012

The Prostate Cancer Charity comments on NICE decision to reject life-extending prostate cancer treatment on appeal.

Prostate cancer in the media | 4th May 2012

The Prostate Cancer Charity comments on new statistics released today by Cancer Research UK which show that the number of men being diagnosed with prostate cancer has now reached more than 40,000 a year.

Fundraising news | Our supporters in action | 30th April 2012

Iceland Foods has presented a cheque for £100,000 to The Prostate Cancer Charity, following the retailer's annual Charity Amateur Golf Classic day. This brought Iceland's total donations to the Charity over the last four years to more than £420,000.

Prostate cancer in the media | Research news | 28th April 2012

The Prostate Cancer Charity comments on the early data released from the PIVOT trial, which is comparing the 10 year survival benefit of prostate surgery versus observation for 731 men with low to medium risk disease.

Campaign news | 24th April 2012

Abiraterone is a new drug which can extend the lives of men with incurable prostate cancer which has stopped responding to other available treatments.